Samaritan Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/08 FY 2008

Late annual filing notification for FY 2008

ended 09/30/08 Q3

Late quarterly filing notification for Q3 2008

ended 06/30/08 Q2

Prospectuses and Registrations Filter

Commission order revoking registration

Removal from listing

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Prospectus supplement

Ownership Filter

Weaver George a Jr

Lang Thomas Arnold

News Filter

Partners “Forgetful” Rat Model to Taconic to Commercialize

HIV Drug Granted IND From FDA

Pharma Receives Pricing Approval in Greece for Rapydan® and Launches Novel Product

Last-Ditch Salvage Therapy SP-01A Fighting “HIV Drug Resistance”, Issued US Patent

Patent Claims Allowed Covering Samaritan’s Alzheimer’s Memory Recovery Drug in Australia

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC